Top 1% — Elite
Vivek Nangia
Interventional Pulmonology · Sleep Medicine
New Delhi, Delhi, India
110 H-Index
1,000 Surgeries
5,000 Lives Saved
31 Years Active
7,303 Total Impact
Overview
Vivek Nangia is a interventional pulmonology specialist with an H-index of 110 at Max Super Speciality Hospital, Saket (Principal Director & Head of Institute). Known for pioneered Pioneer of Medical Thoracoscopy in Delhi and performed 1,000+ verified procedures and impacted an estimated 5,000 lives. Has been published in JAMA oncology, The Lancet. Digital health, Cell and recipient of the undefined (undefined). Based in New Delhi, Delhi, India.
For Patients
- Practicing sleep medicine specialist with 31+ years of experience
- Has performed over 1K+ verified procedures
- Pioneered the Pioneer of Medical Thoracoscopy in Delhi, a technique still used by doctors worldwide
- Has impacted an estimated 5K+ lives through clinical work and research
- Currently at Max Super Speciality Hospital, Saket in New Delhi, India
Biography
Dr. Vivek Nangia is an internationally renowned Interventional Pulmonologist with over three decades of clinical experience. He currently serves as the Principal Director and Head of the Institute of Respiratory, Critical Care, and Sleep Medicine at Max Hospital, Saket. He is a pioneer of Medical Thoracoscopy in Delhi and is recognized for his expertise in critical care, sleep medicine, and infectious diseases.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
Front MicrobiolLung IndiaInt J Antimicrob AgentsIndian J Med MicrobiolPLoS One
Key Publications
Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype.
NCCP-ICS joint consensus-based clinical practice guidelines on medical thoracoscopy.
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
A comparative assessment of clinical, pharmacological and antimicrobial profile of novel anti-methicillin-resistant Staphylococcus aureus agent levonadifloxacin: Therapeutic role in nosocomial and community infections.
COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits.
Areas of Expertise
Pioneering Techniques
Medical Specialties
Clinical Knowledge & Procedures
Media Archive